Galactose clearance in patients with hepatocellular carcinoma. Evaluation of effective hepatic blood flow.
作者信息
Meacci E, Smorlesi C, Chiarantini E, Birardi A, Buzzelli G
出版信息
Boll Soc Ital Biol Sper. 1987 Jun 30;63(6):489-95.
PMID:2820446
Abstract
摘要
相似文献
1
Galactose clearance in patients with hepatocellular carcinoma. Evaluation of effective hepatic blood flow.
Boll Soc Ital Biol Sper. 1987 Jun 30;63(6):489-95.
2
Galactose loading tests in patients with hepatocellular carcinoma for the assessment of chemotherapy.用于评估化疗的肝细胞癌患者半乳糖负荷试验
Chemioterapia. 1987 Aug;6(4):306-9.
3
Correlation of liver function and structure of cirrhosis with and without hepatoma based on autopsy studies.基于尸检研究的伴有和不伴有肝癌的肝硬化患者肝功能与结构的相关性
Acta Pathol Jpn. 1971 Nov;21(4):531-9. doi: 10.1111/j.1440-1827.1971.tb00142.x.
4
Intrahepatic arteriovenous shunting due to hepatocellular carcinoma and cirrhosis, and its change by transcatheter arterial embolization.
Am J Gastroenterol. 1994 Feb;89(2):184-8.
5
The afferent circulation of the liver in patients with primary hepatocellular carcinoma.原发性肝细胞癌患者肝脏的输入循环。
Hepatogastroenterology. 1995 Jul-Aug;42(4):399-402.
6
Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis.对合并肝硬化的肝细胞癌进行肝切除。
Hepatogastroenterology. 2002 Sep-Oct;49(47):1363-8.
7
Effective liver blood flow: determination by galactose clearance.
Can J Surg. 1983 Mar;26(2):129-32.
8
["Partial wrapping therapy" for recurrent hepatocellular carcinoma by transthoracic route].经胸途径对复发性肝细胞癌的“部分包裹疗法”
Gan To Kagaku Ryoho. 1993 Aug;20(11):1489-91.
9
[Primary liver carcinoma a clinical study].
Dtsch Z Verdau Stoffwechselkr. 1973;33(4):193-8.
10
[Differential diagnosis and pathophysiologic principles of ascites].[腹水的鉴别诊断与病理生理原则]
Chirurg. 1993 Jan;64(1):1-6.
Zotero 插件